UniProt ID | TAOK2_MOUSE | |
---|---|---|
UniProt AC | Q6ZQ29 | |
Protein Name | Serine/threonine-protein kinase TAO2 | |
Gene Name | Taok2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 1240 | |
Subcellular Localization |
Cytoplasmic vesicle membrane Multi-pass membrane protein. Cytoplasm, cytoskeleton. Found to be perinuclear and localized to vesicular compartment.. Isoform 2: Cell projection, dendrite. In dendrites, colocalizes with PCDH8.. |
|
Protein Description | Serine/threonine-protein kinase involved in different processes such as membrane blebbing and apoptotic bodies formation DNA damage response and MAPK14/p38 MAPK stress-activated MAPK cascade. Phosphorylates itself, MBP, activated MAPK8, MAP2K3, MAP2K6 and tubulins. Activates the MAPK14/p38 MAPK signaling pathway through the specific activation and phosphorylation of the upstream MAP2K3 and MAP2K6 kinases. In response to DNA damage, involved in the G2/M transition DNA damage checkpoint by activating the p38/MAPK14 stress-activated MAPK cascade, probably by mediating phosphorylation of upstream MAP2K3 and MAP2K6 kinases. May affect microtubule organization and stability. May play a role in the osmotic stress-MAPK8 pathway. Prevents MAP3K7-mediated activation of CHUK, and thus NF-kappa-B activation. Isoform 2, but not isoform 1, is required for PCDH8 endocytosis. Following homophilic interactions between PCDH8 extracellular domains, isoform 2 phosphorylates and activates MAPK14/p38 MAPK which in turn phosphorylates isoform 2. This process leads to PCDH8 endocytosis and CDH2 cointernalization. Both isoforms are involved in MAPK14/p38 MAPK activation (By similarity).. | |
Protein Sequence | MPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEAPNGPGAEAPEEEELTPCSQEAEPYTHRAGTLTSLESSHSVPSMSISASSQSSSVNSLADASDNEEEEEEEEEEEEEEEEEGPESREMAMMQEGEHTVTSHSSIIHRLPGSDNLYDDPYQPEMTPGPLQPPAAPPTSTSSSARRRAYCRNRDHFATIRTASLVSRQIQEHEQDSALREQLSGYKRMRRQHQKQLLALESRLRGEREEHSGRLQRELEAQRAGFGTEAEKLARRHQAIGEKEARAAQAEERKFQQHILGQQKKELAALLEAQKRTYKLRKEQLKEELQENPSTPKREKAEWLLRQKEQLQQCQAEEEAGLLRRQRQYFELQCRQYKRKMLLARHSLDQDLLREDLNKKQTQKDLECALLLRQHEATRELELRQLQAVQRTRAELTRLQHQTELGNQLEYNKRREQELRQKHAAQVRQQPKSLKVRAGQLPMGLPATGALGPLSTGTPSEEQPCSSGQEAILDQRMLGEEEEAVPERRILGKEGTTLEPEEQRILGEEMGTFSSSPQKHRSLANEEDWDISEEMKEIRVPSLASQERNIIGQEEAAAWSLWEKEGGNLVDVEFKLGWVQGPVLTPVPEEEEEEEEEGGAPIGTHRDPGDGCPSPDIPPEPPPSHLRQYPTSQLPGLLSHGLLAGLSFAVGSSSGLLPLLLLLLLPLLAAQGGGGLQAALLALEVGLVGLGASYLFLCTALHLPPGLFLLLAQGTALLAVLSLSWRRGLMGVPLGLGAAWLLAWPSLALPLAAMAAGGKWVRQQGPQMRRGISRLWLRILLRLSPMVFRALQGCGAVGDRGLFALYPKTNKNGFRSRLPVPWPRQGNPRTTQHPLAQLTRVWAVCKGWNWRLARASHRLASCLPPWAVHILASWGLLKGERPSRIPRLLPRSQRRLGLSASRQLPPGTVAGRRSQTRRTLPPWR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
9 | Phosphorylation | PAGGRAGSLKDPDVA CCCCCCCCCCCCCHH | 31.12 | 26824392 | |
43 | Phosphorylation | HGSFGAVYFARDVRN CCCCCCEEEEECCCC | 7.32 | 18034455 | |
51 | Phosphorylation | FARDVRNSEVVAIKK EEECCCCCEEEEEEE | 22.62 | 25338131 | |
160 | Phosphorylation | KAGNILLSEPGLVKL CCCCEEECCCCEEEC | 38.00 | 28285833 | |
174 | Phosphorylation | LGDFGSASIMAPANS CCCCCCCEEEECCCC | 18.00 | 23649490 | |
181 | Phosphorylation | SIMAPANSFVGTPYW EEEECCCCCCCCCCC | 24.34 | 23649490 | |
309 | Phosphorylation | RELDNLQYRKMKKIL HHHHHHHHHHHHHHH | 18.50 | 29514104 | |
419 | Phosphorylation | EGEHTVTSHSSIIHR CCCCEECCCHHHHHC | 19.62 | 29899451 | |
422 | Phosphorylation | HTVTSHSSIIHRLPG CEECCCHHHHHCCCC | 21.82 | - | |
466 | Phosphorylation | SSARRRAYCRNRDHF CHHHHHHHHCCCCCH | 7.07 | 29514104 | |
475 | Phosphorylation | RNRDHFATIRTASLV CCCCCHHHHHHHHHH | 15.28 | 27600695 | |
478 | Phosphorylation | DHFATIRTASLVSRQ CCHHHHHHHHHHHHH | 19.42 | 26745281 | |
480 | Phosphorylation | FATIRTASLVSRQIQ HHHHHHHHHHHHHHH | 28.79 | 24453211 | |
483 | Phosphorylation | IRTASLVSRQIQEHE HHHHHHHHHHHHHHH | 24.62 | 28066266 | |
493 | Phosphorylation | IQEHEQDSALREQLS HHHHHHCHHHHHHHH | 28.97 | 25521595 | |
500 | Phosphorylation | SALREQLSGYKRMRR HHHHHHHHHHHHHHH | 39.51 | 29514104 | |
502 | Phosphorylation | LREQLSGYKRMRRQH HHHHHHHHHHHHHHH | 7.64 | 29899451 | |
610 | Phosphorylation | EELQENPSTPKREKA HHHHHCCCCCHHHHH | 69.77 | - | |
611 | Phosphorylation | ELQENPSTPKREKAE HHHHCCCCCHHHHHH | 33.80 | - | |
663 | Phosphorylation | KMLLARHSLDQDLLR HHHHHHHCCCHHHHH | 28.25 | 25521595 | |
675 | Acetylation | LLREDLNKKQTQKDL HHHHHHCHHHHHHHH | 54.26 | 19857369 | |
738 | Acetylation | REQELRQKHAAQVRQ HHHHHHHHHHHHHHH | 28.86 | 8276525 | |
748 | Acetylation | AQVRQQPKSLKVRAG HHHHHCCCCCCCCCC | 65.17 | 8276539 | |
782 | Phosphorylation | PSEEQPCSSGQEAIL CCCCCCCCCCHHHHH | 44.16 | - | |
830 | Phosphorylation | GEEMGTFSSSPQKHR HCCCCCCCCCHHHHH | 29.73 | 26643407 | |
831 | Phosphorylation | EEMGTFSSSPQKHRS CCCCCCCCCHHHHHH | 41.67 | 26643407 | |
832 | Phosphorylation | EMGTFSSSPQKHRSL CCCCCCCCHHHHHHH | 30.10 | 26643407 | |
993 (in isoform 2) | Phosphorylation | - | 28.06 | 29514104 | |
995 (in isoform 2) | Phosphorylation | - | 7.08 | 29514104 | |
997 (in isoform 2) | Phosphorylation | - | 4.36 | 29514104 | |
999 (in isoform 2) | Methylation | - | 5.74 | 24129315 | |
1009 (in isoform 2) | Phosphorylation | - | 22.14 | 26745281 | |
1018 (in isoform 2) | Phosphorylation | - | 33.55 | 25521595 | |
1021 (in isoform 2) | Phosphorylation | - | 59.48 | 25521595 | |
1022 (in isoform 2) | Phosphorylation | - | 27.41 | 30372032 | |
1037 (in isoform 2) | Phosphorylation | - | 3.38 | 20415495 | |
1039 (in isoform 2) | Phosphorylation | - | 5.07 | 21183079 | |
1041 (in isoform 2) | Phosphorylation | - | 10.17 | 25177544 | |
1044 (in isoform 2) | Phosphorylation | - | 16.08 | 21183079 | |
1054 (in isoform 2) | Phosphorylation | - | 10.66 | 29514104 | |
1230 | Phosphorylation | GTVAGRRSQTRRTLP CCCCCCCCCCCCCCC | 34.25 | 24719451 | |
1232 | Phosphorylation | VAGRRSQTRRTLPPW CCCCCCCCCCCCCCC | 24.30 | 24719451 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
475 | T | Phosphorylation | Kinase | MST3 | Q9Y6E0 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
1037 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAOK2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CLUS_HUMAN | CLU | physical | 26496610 | |
IF4G1_HUMAN | EIF4G1 | physical | 26496610 | |
RENT1_HUMAN | UPF1 | physical | 26496610 | |
RCOR3_HUMAN | RCOR3 | physical | 26496610 | |
CHM4B_HUMAN | CHMP4B | physical | 26496610 | |
PPR18_HUMAN | PPP1R18 | physical | 26496610 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale identification and evolution indexing of tyrosinephosphorylation sites from murine brain."; Ballif B.A., Carey G.R., Sunyaev S.R., Gygi S.P.; J. Proteome Res. 7:311-318(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-43, AND MASSSPECTROMETRY. |